79 related articles for article (PubMed ID: 19745592)
1. Phase II STUdy with 3rd- or 4th-line bendamustine (flat dose) therapy in patients with metastatic breast cancer.
Steinbild S; Frost A; Häring B; Unger C; Mross K
Onkologie; 2009 Sep; 32(8-9):488-92. PubMed ID: 19745592
[TBL] [Abstract][Full Text] [Related]
2. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Loibl S; Murmann C; Schwedler K; Warm M; Müller L; Heinrich G; Nekljudova V; von Minckwitz G
Cancer Chemother Pharmacol; 2009 Apr; 63(5):953-8. PubMed ID: 18716777
[TBL] [Abstract][Full Text] [Related]
3. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Eichbaum MH; Schuetz F; Khbeis T; Lauschner I; Foerster F; Sohn C; Schneeweiss A
Anticancer Drugs; 2007 Sep; 18(8):963-8. PubMed ID: 17667603
[TBL] [Abstract][Full Text] [Related]
4. Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
Hartmann JT; Mayer F; Schleicher J; Horger M; Huober J; Meisinger I; Pintoffl J; Käfer G; Kanz L; Grünwald V;
Cancer; 2007 Aug; 110(4):861-6. PubMed ID: 17599772
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group.
Bergmann MA; Goebeler ME; Herold M; Emmerich B; Wilhelm M; Ruelfs C; Boening L; Hallek MJ;
Haematologica; 2005 Oct; 90(10):1357-64. PubMed ID: 16219572
[TBL] [Abstract][Full Text] [Related]
6. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.
Knauf WU; Lissichkov T; Aldaoud A; Liberati A; Loscertales J; Herbrecht R; Juliusson G; Postner G; Gercheva L; Goranov S; Becker M; Fricke HJ; Huguet F; Del Giudice I; Klein P; Tremmel L; Merkle K; Montillo M
J Clin Oncol; 2009 Sep; 27(26):4378-84. PubMed ID: 19652068
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors.
Rasschaert M; Schrijvers D; Van den Brande J; Dyck J; Bosmans J; Merkle K; Vermorken JB
Anticancer Drugs; 2007 Jun; 18(5):587-95. PubMed ID: 17414628
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of bendamustine in advanced bile duct cancer.
Schoppmeyer K; Kreth F; Wiedmann M; Mössner J; Preiss R; Caca K
Anticancer Drugs; 2007 Jul; 18(6):697-702. PubMed ID: 17762399
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
Smith JW; McIntyre KJ; Acevedo PV; Encarnacion CA; Tedesco KL; Wang Y; Asmar L; O'Shaughnessy JA
Breast Cancer Res Treat; 2009 Nov; 118(2):361-7. PubMed ID: 19459042
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and toxicity of bendamustine in recurrent multiple myeloma after high-dose chemotherapy.
Knop S; Straka C; Haen M; Schwedes R; Hebart H; Einsele H
Haematologica; 2005 Sep; 90(9):1287-8. PubMed ID: 16154860
[TBL] [Abstract][Full Text] [Related]
11. Bendamustine in the treatment of chronic lymphocytic leukemia.
Knauf W
Expert Rev Anticancer Ther; 2009 Feb; 9(2):165-74. PubMed ID: 19192955
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.
Ellard SL; Clemons M; Gelmon KA; Norris B; Kennecke H; Chia S; Pritchard K; Eisen A; Vandenberg T; Taylor M; Sauerbrei E; Mishaeli M; Huntsman D; Walsh W; Olivo M; McIntosh L; Seymour L
J Clin Oncol; 2009 Sep; 27(27):4536-41. PubMed ID: 19687332
[TBL] [Abstract][Full Text] [Related]
13. Bendamustine: rebirth of an old drug.
Cheson BD; Rummel MJ
J Clin Oncol; 2009 Mar; 27(9):1492-501. PubMed ID: 19224851
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours.
Schöffski P; Hagedorn T; Grünwald V; Paul H; Merkle K; Kowalski R; Ganser A
J Cancer Res Clin Oncol; 2000 Jan; 126(1):41-7. PubMed ID: 10641748
[TBL] [Abstract][Full Text] [Related]
15. Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II study.
Höffken K; Merkle K; Schönfelder M; Anger G; Brandtner M; Ridwelski K; Seeber S
J Cancer Res Clin Oncol; 1998; 124(11):627-32. PubMed ID: 9860292
[TBL] [Abstract][Full Text] [Related]
16. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
Trudeau ME; Clemons MJ; Provencher L; Panasci L; Yelle L; Rayson D; Latreille J; Vandenberg T; Goel R; Zibdawi L; Rahim Y; Pouliot JF
J Clin Oncol; 2009 Dec; 27(35):5906-10. PubMed ID: 19858391
[TBL] [Abstract][Full Text] [Related]
17. Bendamustine: a new look at an old drug.
Kalaycio M
Cancer; 2009 Feb; 115(3):473-9. PubMed ID: 19117340
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer.
Bianchi G; Loibl S; Zamagni C; Salvagni S; Raab G; Siena S; Laferriere N; Peña C; Lathia C; Bergamini L; Gianni L
Anticancer Drugs; 2009 Aug; 20(7):616-24. PubMed ID: 19739318
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer.
Klippstein A; Schneider CP; Sayer HG; Höffken K
J Cancer Res Clin Oncol; 2003 May; 129(5):316-9. PubMed ID: 12756557
[TBL] [Abstract][Full Text] [Related]
20. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.
Reichmann U; Bokemeyer C; Wallwiener D; Bamberg M; Huober J
Ann Oncol; 2007 Dec; 18(12):1981-4. PubMed ID: 17872900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
